Cargando…

A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques

Replicative vectors derived from live-attenuated measles virus (MV) carrying additional non-measles vaccine antigens have long demonstrated safety and immunogenicity in humans despite pre-existing immunity to measles. Here, we report the vaccination of cynomolgus macaques with MV replicative vectors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nzounza, Patrycja, Martin, Grégoire, Dereuddre-Bosquet, Nathalie, Najburg, Valérie, Gosse, Leslie, Ruffié, Claude, Combredet, Chantal, Petitdemange, Caroline, Souquère, Sylvie, Schlecht-Louf, Géraldine, Moog, Christiane, Pierron, Gérard, Le Grand, Roger, Heidmann, Thierry, Tangy, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536681/ https://www.ncbi.nlm.nih.gov/pubmed/34686669 http://dx.doi.org/10.1038/s41541-021-00385-6

Ejemplares similares

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
por: Tangy, F, et al.
Publicado: (2009)

Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen
por: Jacob, Daria, et al.
Publicado: (2017)

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice
por: Mura, Marie, et al.
Publicado: (2019)

Whole Pichia pastoris Yeast Expressing Measles Virus Nucleoprotein as a Production and Delivery System to Multimerize Plasmodium Antigens
por: Jacob, Daria, et al.
Publicado: (2014)

Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013)

Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2023)

Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells
por: Achard, Carole, et al.
Publicado: (2016)

Antitumor Virotherapy by Attenuated Measles Virus (MV)
por: Guillerme, Jean-Baptiste, et al.
Publicado: (2013)

Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
por: Escriou, Nicolas, et al.
Publicado: (2014)

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65–iASPP Protein Complex
por: Meignié, Alice, et al.
Publicado: (2021)

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
por: Achard, Carole, et al.
Publicado: (2015)

Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
por: Nishimura, Yoshiaki, et al.
Publicado: (2020)

The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy
por: Schlecht-Louf, Géraldine, et al.
Publicado: (2022)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
por: Frantz, Phanramphoei N., et al.
Publicado: (2021)

Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response
por: Khalfi, Pierre, et al.
Publicado: (2023)

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015)

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
por: Ng, Cherie T., et al.
Publicado: (2010)

Sustained Autophagy Contributes to Measles Virus Infectivity
por: Richetta, Clémence, et al.
Publicado: (2013)

Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
por: Blasi, Maria, et al.
Publicado: (2020)

Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART
por: Obregon-Perko, Veronica, et al.
Publicado: (2021)

MiniCD4 Microbicide Prevents HIV Infection of Human Mucosal Explants and Vaginal Transmission of SHIV(162P3) in Cynomolgus Macaques
por: Dereuddre-Bosquet, Nathalie, et al.
Publicado: (2012)

Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
por: Le Grand, Roger, et al.
Publicado: (2016)

CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge
por: Ariën, Kevin K., et al.
Publicado: (2016)

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection
por: Evangelous, Tyler D., et al.
Publicado: (2023)

Viremia in human Cowpox virus infection
por: Nitsche, Andreas, et al.
Publicado: (2007)

NK-B cell cross talk induces CXCR5 expression on natural killer cells
por: Rascle, Philippe, et al.
Publicado: (2021)

Measles Virus
por: Davaro, Raul E.
Publicado: (2013)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates
por: Bayon, Emilie, et al.
Publicado: (2018)

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
por: Moog, C, et al.
Publicado: (2012)

Glucocorticoid-Induced Leucine Zipper: Fine-Tuning of Dendritic Cells Function
por: Vétillard, Mathias, et al.
Publicado: (2018)

Residual Viremia in an RT-SHIV Rhesus Macaque HAART Model Marked by the Presence of a Predominant Plasma Clone and a Lack of Viral Evolution
por: Kauffman, Robert C., et al.
Publicado: (2014)

Hepatitis C virus RNA viremia in Central Africa.
por: Cancré, N, et al.
Publicado: (1999)

West Nile Virus Viremia in Wild Rock Pigeons
por: Allison, Andrew B., et al.
Publicado: (2004)

Virus Cooperation, ZIKV Viremia and in Utero Fetus Infection
por: Goldschmidt-Clermont, Pascal J., et al.
Publicado: (2019)

STUDIES ON MEASLES : I. SUSCEPTIBILITY OF MONKEYS TO THE VIRUS OF MEASLES.
por: Blake, Francis G., et al.
Publicado: (1921)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_okldgomqvvkfjjic85r70chj3o